Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00282139
Status:
TERMINATED
Last Update Posted:
2011-10-05
First Post:
2006-01-23
Brief Title:
Aripiprazole in the Treatment of Tourettes Syndrome
Sponsor:
University of Florida
Organization:
University of Florida
Study Overview
Official Title:
Aripiprazole in the Treatment of Tourettes Syndrome
Status:
TERMINATED
Status Verified Date:
2011-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open-label flexible dose study designed to evaluate the safety and efficacy of aripiprazole in TS or chronic tic disorder subjects with or without associated OC symptoms and with or without ADHD symptoms
Detailed Description:
This is an open-label flexible dose study designed to evaluate the safety and efficacy of aripiprazole in TS or chronic tic disorder subjects with or without associated OC symptoms and with or without ADHD symptoms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 0004025600042966 | None | None | None |